X0306 4/A 2020-12-04 2020-12-07 0 0001310488 BIOFORCE NANOSCIENCES HOLDINGS, INC. BFNH 0001663787 KAISER RICHARD KAISER 3419 VIRGINIA BEACH BLVD, UNIT 252 VIRGINIA BEACH VA 23452 1 1 1 0 CFO Common Stock 2020-12-04 4 A 0 3000000 0.001 A 5050000 D Convertible Preferred 'A' 0.001 2020-12-04 4 M 0 500000 0.001 D 2020-12-31 2040-12-31 Common Stock 3000000 0 D On December 4, 2020, BioForce Nanosciences Holdings, Inc. (The "Company" or the "Registrant") issued 3,000,000 shares of its common stock to the reporting individual in exchange for 500,000 shares of its Preferred Series 'A' shares. These shares were issued pursuant to an exemption from registration provided by Section 4(2) of the Securities Act of 1933. The issuance was not a public offering as defined in Section4(2)due to the limited number of persons that received the shares, and the matter of the issuances. In addition, the transferee of the common stock represented that they had the necessary investment intent as required by Section 4(2) and agreed to receive shares containing a legend that states the securities were restricted pursuant to Rule 144 of the Securities Act. This amendment No. 2 on FORM 4/A is being filed to fix TABLE II, column #5 whereas the "Number of Derivate Securities" was marked wrongly as being "Acquired" on both the original FORM 4 and The amendment No. 1 of FORM 4/A. The reporting individual "Disposed" of 500,000 shares which is now the correct designation on this FORM 4/A No. 2 filing. /s/ Richard Kaiser 2020-12-09